On Oct. 1, the U.S. health care system will begin to use the International Classification of Diseases 10th edition ─ it replaces the decades-old 9th edition. This represents the largest change in coding since the revision of evaluation and management CPT codes in 1992.According to a blog post by William D. Rogers, MD, FACEP, ICD-10 Ombudsman at CMS, ICD-10 promises to help physicians and other health care providers better coordinate care, keep more detailed records and more accurately define patients’ clinical conditions, as well as implement new payment methods. It will also allow for data comparisons between regions of the United States and the rest of the world, and may help improve clinical and surgical practice guidelines across the entire spectrum of health care services.
Ready or Not: It’s ICD-10 Time
(MedPage Today) — Are you ready for some chaos?
pSivida plans to submit NDA for Medidur using 6-month efficacy data
pSivida plans to submit a new drug application to the FDA for Medidur to treat posterior uveitis, according to a press release. The NDA, expected to be submitted in the first half of 2017, will be based on 6-month efficacy data of Medidur (sustained-re…
Using well-worded warning texts could reduce DNAs, potentially save NHS £64 million
As many as 400,000 missed hospital appointments a year could be prevented simply by using well-worded warning texts, potentially saving the NHS £64 million.
ICON Eyecare Kicks Off Colorado’s Tour of The Moon Cycling Event
GRAND JUNCTION, Colo.–(BUSINESS WIRE)–Hundreds of cycling enthusiasts will gather at The Colorado Riverfront Commission for a morning of riding and giving back to their community
Aura Biosciences Forms Clinical Advisory Board in Ocular Oncology and Strengthens Clinical Team to Prepare for Clinical Development of Lead Program in Ocular Melanoma
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences, a biotechnology company developing a new class of therapies to target and selectively destroy cancer cells, announced today that it has formed a Clinical Advisory Board in Ocular Oncology and bolster…